Skip to content

Primary Vitrectomy With Endolaser or Encircling Band for Rhegmatogenous Retinal Detachment

Primary Vitrectomy Combined With 360° Endolaser or Encircling Band for Rhegmatogenous Retinal Detachment (V.E.E. Study)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00757536
Enrollment
60
Registered
2008-09-23
Start date
2006-05-31
Completion date
2012-12-31
Last updated
2016-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Encircling Band, Endolaser Treatment, Primary Vitrectomy, Rhegmatogenous Retinal Detachment

Keywords

Rhegmatogenous retinal detachment, primary vitrectomy, encircling band, endolaser treatment

Brief summary

Comparing primary PPV with 360° endolaser photocoagulation with primary PPV with an encircling band for patients with RRDs.

Detailed description

published

Interventions

PROCEDUREEncircling Band

ppVE and encircling band

PROCEDUREEndolaser Photocoagulation

ppVE and endolaser photocoagulation

Sponsors

The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Primary rhegmatogenous retinal detachment with or without macula-off detachment phakic or pseudophakic eyes * Multiple breaks, inferior and posterior located breaks or unclear hole formation * Proliferative vitreoretinopathy (PVR) stage A and B

Exclusion criteria

* Previous retinal detachment surgery * Giant tears * PVR stage C * Age less than 18 years

Design outcomes

Primary

MeasureTime frame
Retinal redetachment rate6 months

Secondary

MeasureTime frame
Surgery-related complications, patients' comfort, refractive change, visual acuity and optical coherence tomography.6 months

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026